D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 43 Citations 10,861 146 World Ranking 3000 National Ranking 192

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Virus

J. K. Rockstroh focuses on Immunology, Acquired immunodeficiency syndrome, Internal medicine, Hepatitis C and Viral disease. His Immunology research is multidisciplinary, incorporating elements of Glutathione peroxidase, Liver disease and Asymptomatic. His Acquired immunodeficiency syndrome study combines topics from a wide range of disciplines, such as Hepatitis B, Hepatitis, Virology and T cell.

J. K. Rockstroh combines subjects such as Logistic regression, Malignancy, Circulating MicroRNA, Case-control study and Human leukocyte antigen with his study of T cell. His work in Internal medicine addresses subjects such as Viral load, which are connected to disciplines such as Confidence interval. The Hepatitis C study which covers Coinfection that intersects with Cirrhosis and Intensive care medicine.

His most cited work include:

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study (2421 citations)
  • Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel. (298 citations)
  • HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8+ T Cell Response against HIV-1 (278 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Internal medicine, Virology, Immunology, Acquired immunodeficiency syndrome and Gastroenterology. J. K. Rockstroh has researched Internal medicine in several fields, including Ribavirin and Viral load. His Virology study frequently involves adjacent topics like Genotype.

His Immunology research incorporates elements of Liver disease and Incidence. He has included themes like Pediatrics and Immunopathology in his Acquired immunodeficiency syndrome study. His studies in Gastroenterology integrate themes in fields like Adverse effect, Pharmacology, Discontinuation and Ritonavir.

He most often published in these fields:

  • Internal medicine (45.60%)
  • Virology (32.90%)
  • Immunology (29.64%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (45.60%)
  • Virology (32.90%)
  • Hepatitis C virus (15.31%)

In recent papers he was focusing on the following fields of study:

J. K. Rockstroh mainly focuses on Internal medicine, Virology, Hepatitis C virus, Hepatitis C and Gastroenterology. The various areas that J. K. Rockstroh examines in his Internal medicine study include Hcv therapy and Reverse-transcriptase inhibitor. Within one scientific family, J. K. Rockstroh focuses on topics pertaining to Cirrhosis under Hepatitis C virus, and may sometimes address concerns connected to Hepatitis.

His Hepatitis C study incorporates themes from Odds ratio, Virological response, Sofosbuvir, Coinfection and Cohort. His Cohort research is multidisciplinary, incorporating elements of Men who have sex with men, Acquired immunodeficiency syndrome and Ribavirin. In Acquired immunodeficiency syndrome, J. K. Rockstroh works on issues like Risk factor, which are connected to Hazard ratio.

Between 2016 and 2021, his most popular works were:

  • Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial (58 citations)
  • High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance-associated substitutions in hepatitis C genotype 3 infection. (33 citations)
  • Rates of sustained virological response 12 weeks after the scheduled end of direct-acting antiviral (DAA)-based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy? (26 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Virus

His scientific interests lie mostly in Internal medicine, Hepatitis C virus, Randomized controlled trial, Virology and Hepatitis C. The various areas that J. K. Rockstroh examines in his Internal medicine study include Gastroenterology and Tenofovir alafenamide. The Randomized controlled trial study combines topics in areas such as Liver disease, Emtricitabine, Regimen and Ritonavir.

His study in the field of Glecaprevir / pibrentasvir, Varicella zoster virus, Vaccination and Measles also crosses realms of In patient. His work carried out in the field of Hepatitis C brings together such families of science as Ribavirin, Sofosbuvir and Cohort. J. K. Rockstroh combines subjects such as Fibrosis, Men who have sex with men, Acquired immunodeficiency syndrome and Odds ratio with his study of Hazard ratio.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka.
PLOS ONE (2015)

3959 Citations

Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel.

Vincent Soriano;Massimo Puoti;Mark Sulkowski;Antonietta Cargnel.
AIDS (2007)

445 Citations

HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8+ T Cell Response against HIV-1

Marcus Altfeld;Elizabeth T Kalife;Ying Qi;Hendrik Streeck.
PLOS Medicine (2006)

373 Citations

Antiretroviral drugs and liver injury

Vincent Soriano;Massimo Puoti;Pilar Garcia-Gascó;Juergen K Rockstroh.
AIDS (2008)

254 Citations

Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel.

Vincent Soriano;Massimo Puoti;Marion Peters;Yves Benhamou.
AIDS (2008)

218 Citations

Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV

J K Rockstroh;U Spengler;T Sudhop;S Ewig.
The American Journal of Gastroenterology (1996)

201 Citations

Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe

Soriano;A Mocroft;J Rockstroh;B Ledergerber.
The Journal of Infectious Diseases (2008)

198 Citations

Acute hepatitis C in HIV-infected individuals : recommendations from the European AIDS Treatment Network (NEAT) consensus conference The European AIDS Treatment Network (NEAT) Acute Hepatitis C Infection Consensus Panel

Matthieu Albert;Jose Benito;Sanjay Bhagani;Christoph Boesecke.
AIDS (2010)

191 Citations

Serum selenium, plasma glutathione (GSH) and erythrocyte glutathione peroxidase (GSH-Px)-levels in asymptomatic versus symptomatic human immunodeficiency virus-1 (HIV-1)-infection.

M P Look;J K Rockstroh;G S Rao;K A Kreuzer.
European Journal of Clinical Nutrition (1997)

185 Citations

HIV and viral hepatitis coinfections: advances and challenges

Karine Lacombe;Juergen Rockstroh.
Gut (2012)

166 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing JK Rockstroh

Vincent Soriano

Vincent Soriano

Hospital Universitario La Paz

Publications: 110

Jürgen K. Rockstroh

Jürgen K. Rockstroh

University Hospital Bonn

Publications: 102

Bruce D. Walker

Bruce D. Walker

Harvard University

Publications: 81

Pablo Barreiro

Pablo Barreiro

Hospital Universitario La Paz

Publications: 73

Jens D. Lundgren

Jens D. Lundgren

Rigshospitalet

Publications: 45

Juan A. Pineda

Juan A. Pineda

Spanish National Research Council

Publications: 44

Massimo Puoti

Massimo Puoti

University of Brescia

Publications: 43

Marina B. Klein

Marina B. Klein

McGill University Health Centre

Publications: 39

Zabrina L. Brumme

Zabrina L. Brumme

Simon Fraser University

Publications: 38

Gail V. Matthews

Gail V. Matthews

UNSW Sydney

Publications: 38

Gregory J. Dore

Gregory J. Dore

UNSW Sydney

Publications: 35

Antonella d'Arminio Monforte

Antonella d'Arminio Monforte

University of Milan

Publications: 35

Amanda Mocroft

Amanda Mocroft

University College London

Publications: 33

Antonio Rivero

Antonio Rivero

Instituto Maimónides de Investigación Biomédica de Córdoba

Publications: 33

Douglas T. Dieterich

Douglas T. Dieterich

Icahn School of Medicine at Mount Sinai

Publications: 32

Peter Reiss

Peter Reiss

University of Amsterdam

Publications: 31

Something went wrong. Please try again later.